- Home
- PHIO vs ADN Comparison
PHIO vs ADN Comparison
Compare PHIO & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- ADN
- Stock Information
- Founded
- PHIO 2011
- ADN 2006
- Country
- PHIO United States
- ADN United States
- Employees
- PHIO N/A
- ADN N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- PHIO Health Care
- ADN Utilities
- Exchange
- PHIO Nasdaq
- ADN Nasdaq
- Market Cap
- PHIO 8.6M
- ADN 7.5M
- IPO Year
- PHIO N/A
- ADN N/A
- Fundamental
- Price
- PHIO $2.00
- ADN $2.45
- Analyst Decision
- PHIO Strong Buy
- ADN
- Analyst Count
- PHIO 1
- ADN 0
- Target Price
- PHIO $4.00
- ADN N/A
- AVG Volume (30 Days)
- PHIO 875.3K
- ADN 41.4K
- Earning Date
- PHIO 05-15-2025
- ADN 12-27-2024
- Dividend Yield
- PHIO N/A
- ADN N/A
- EPS Growth
- PHIO N/A
- ADN N/A
- EPS
- PHIO N/A
- ADN N/A
- Revenue
- PHIO N/A
- ADN $8,157,000.00
- Revenue This Year
- PHIO N/A
- ADN $2,232.99
- Revenue Next Year
- PHIO N/A
- ADN $91.56
- P/E Ratio
- PHIO N/A
- ADN N/A
- Revenue Growth
- PHIO N/A
- ADN 274.35
- 52 Week Low
- PHIO $0.97
- ADN $1.71
- 52 Week High
- PHIO $9.79
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- PHIO 54.98
- ADN 45.95
- Support Level
- PHIO $1.71
- ADN $2.00
- Resistance Level
- PHIO $2.08
- ADN $3.07
- Average True Range (ATR)
- PHIO 0.13
- ADN 0.27
- MACD
- PHIO 0.01
- ADN 0.04
- Stochastic Oscillator
- PHIO 76.32
- ADN 42.25
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.